A small molecule protected neurons and extended survival in TDP-43 ALS models
Original source
Therapeutic targeting of the conserved region within the low-complexity domain of TDP-43 is neuroprotective and extends survival in amyotrophic lateral sclerosis mice. (opens in a new tab)Compass summarised this from the study's abstract.
Study details
- Studied in
- Human, Mouse
Related topics
Researchers identified a conserved region of TDP-43 that can be targeted to reduce its toxicity. The small molecule XL20 protected neurons, reduced motor neuron loss and extended survival in ALS mice carrying TDP-43 mutations. It also improved neuronal function in human ALS motor neurons grown from induced pluripotent stem cells.
Why this matters
The findings identify a possible drug target for TDP-43-related ALS and support further testing of XL20-like molecules. This is preclinical research in mice and lab-grown human neurons, so it does not yet change treatment for people with ALS.
Limitations and context
The evidence comes from a single primary research study. The work used ALS mouse models and induced pluripotent stem cell-derived motor neurons, not people with ALS; human safety and treatment benefit have not been established. The proposed mechanism is described as likely and requires further confirmation.